查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1679381

全球藥用脂質輔料市場：市場規模、佔有率和趨勢分析（按輔料類型、產品用途、疾病用途、行業用途、年齡層、最終用途和地區）、按細分市場預測（2025-2030 年）

Pharmaceutical Lipid-Based Excipients Market Size, Share & Trends Analysis Report By Excipient Type, By Product Applications, By Disease Application, By Industry Application, By Age Group, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 400 Pages | 商品交期: 2-10個工作天內

價格

藥用脂質輔料市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球藥用脂質輔料市場規模預計到2030年將達到24.2億美元，預測期內的複合年成長率為4.8%。溶解性差的候選藥物佔候選藥物管線的 87%，其數量的增加推動了先進輔料解決方案的採用。固體脂質奈米顆粒和自乳化藥物傳遞系統等脂質基賦形劑對於複雜分子有效解決配方挑戰至關重要。這種激增反映了製藥業需要創新解決方案來提高藥物的生物有效性和功效。

脂質輔料的整合徹底改變了 mRNA 疫苗和基因療法，這在 COVID-19 大流行期間得到了突顯。此外，主要藥物的專利到期也進一步增加了對具有成本效益的輔料的需求。這些因素凸顯了脂質輔料在現代藥物開發中的變革性影響及其在推動藥物傳遞創新中的作用。

人工智慧 (AI) 和配方技術的進步進一步促進了脂質輔料市場的成長。人工智慧主導的建模加速了基於脂質的配方，提高了可預測性並縮短了上市時間。監管機構對脂質輔料寄予厚望，透過關注純度和安全特性將患者安全放在首位，最終確保藥品品質和療效。

藥用脂質輔料市場：分析概述

  • 基於輔料，油脂輔料佔據市場主導地位，佔 2024 年總收入的 40.5%，這得益於脂質藥物輸送、營養保健品的使用和對永續成分的需求的進步。
  • 預測期內，卵磷脂和磷脂部分預計將以強勁的複合年成長率成長。
  • 根據產品應用，外用製劑將在 2024 年佔據市場最大收益佔有率，而眼科應用預計在預測期內以 6.7% 的最快速度成長。
  • 根據疾病，脂質輔料的腫瘤學應用將在 2024 年獲得最大的收益。
  • 根據行業垂直性，膳食補充劑和其他部門預計將在預測期內實現最快的複合年成長率，這得益於脂質輔料製造商和專門從事補充劑的製藥公司之間的戰略夥伴關係關係。
  • 隨著與老齡化相關的疾病變得越來越普遍，老年產品（65 歲及以上）部分預計在預測期內的複合年成長率將超過 5.0%。
  • 根據最終用途，預計製藥商將在 2024 年成為市場的主要最終用戶，佔總收入的 64.9%。
  • 2024 年 4 月，IOI Oleo GmbH 為化妝品產業推出了 DYNASA CrystalCONTROL L。該產品解決了棒狀配方中的「開花」效應，提高了產品穩定性和美觀度，從而讓全球的加工過程無憂無慮。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第 3 章製造商觀點：市場促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
    • 市場機會分析
    • 市場問題分析
  • 藥用脂質輔料市場：分析工具
    • 波特五力分析
  • 分析客戶需求、問題和利益

第4章藥用脂質輔料企業競爭格局

  • 公司/競爭對手分類（領先創新者、市場領導、新興企業）
  • 脂質輔料製造商簡介
    • ABITEC（ABF INGREDIENTS）.
    • BASF CORPORATION
    • GATTEFOSSE
    • CORDENPHARMA
    • LIPOID GMBH
    • IOI OLEO GMBH
    • CRODA INTERNATIONAL PLC
    • EVONIK INDUSTRIES AG
    • ASHLAND
    • MERCK KGAA
  • 公司市場佔有率分析（2024 年）
  • 熱圖分析

第 5 章 最終使用者觀點：市場促進因素、趨勢與範圍

  • 藥用脂質輔料市場展望：最終用戶（購買者/消費者公司）的觀點
    • 市場促進因素分析
    • 市場機會分析
    • 市場限制分析
    • 市場問題分析
  • 分析藥用脂質輔料市場的工具
    • 波特五力分析

第6章 終端使用者分析的競爭格局（買方/消費者企業）

  • 公司/競爭對手分類（領先創新者、市場領導、新興企業）
  • 買家/消費者公司簡介
    • TEVA PHARMACEUTICAL INDUSTRIES LTD.
    • VIATRIS INC.（FORMERLY MYLAN）
    • SANDOZ（A DIVISION OF NOVARTIS）
    • SUN PHARMACEUTICAL INDUSTRIES LTD.
    • CIPLA LTD.
    • DR. REDDY'S LABORATORIES LTD.
    • AUROBINDO PHARMA LTD.
    • LUPIN LTD.
    • ZYDUS LIFESCIENCES LTD.（FORMERLY CADILA）
    • HIKMA PHARMACEUTICALS PLC
  • Heatmap analysis

7. 藥用脂質輔料市場按輔料類型分類（2018-2030 年）

  • 藥用脂質輔料市場：依輔料類型分析
  • 依輔料類型（2018-2030 年）
    • 脂肪和油
    • 氫化植物油
    • GMCC
    • 硬脂
    • 中長鏈三酸甘油酯(MCTS)
    • 卵磷脂和磷脂
    • 油酸鈉
    • 辛酸單雙雙酸甘油酯
    • 其他賦形劑類型

8. 藥用脂質輔料市場依產品應用分類（2018-2030 年）

  • 藥用脂質輔料市場：依產品應用分析
  • 依產品應用（2018-2030 年）
    • 口服製劑
    • 腸外
    • 局部應用程式
    • 眼科應用
    • 栓劑
    • 其他產品應用

9. 藥用脂質輔料市場依疾病應用分類（2018-2030 年）

  • 藥用脂質輔料市場：依疾病應用分析
  • 依疾病用途分類（2018-2030 年）
    • 心血管疾病
    • 神經系統疾病
    • 腫瘤學
    • 代謝紊亂
    • 荷爾蒙療法
    • 感染疾病
    • 應用於其他疾病

10. 藥用脂質輔料市場按產品產業分類（2018-2030 年）

  • 藥用脂質輔料市場：依產品產業分析
  • 按產品產業（2018-2030 年）
    • 藥品（OTC/RX）
    • 膳食補充劑（食品補充劑等）

11. 藥用脂質輔料市場按年齡層別分類的產品狀況（2018-2030 年）

  • 藥用脂質輔料市場按年齡分類的產品
  • 各年齡層產品（2018-2030）
    • 兒童產品（0-18歲）
    • 成人用品（19-64歲）
    • 老年人產品（65歲以上）

12. 醫藥脂質輔料市場依最終用途分類（2018-2030 年）

  • 藥用脂質輔料市場：最終用途產品分析
  • 依最終用途分類（2018-2030 年）
    • 製藥商
    • 合約開發與製造組織 (CDMOS)
    • 其他

第 13 章：藥用脂質輔料市場：按地區分類的估計和趨勢分析

  • 藥用脂質輔料市場：區域展望
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 中國
    • 印度
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 約旦
    • 埃及
    • 伊朗
    • 科威特

第14章 競爭格局

  • 市場參與企業分類
  • 企業市場分析/堆圖分析
  • 戰略地圖
    • 企業合併與收購 (M&A)
    • 夥伴關係和合作
    • 其他
  • 公司簡介
    • ABITEC Corporation
    • BASF
    • Gattefosse
    • CordenPharma
    • Lipoid
    • IOI Oleo GmbH
    • Croda International
    • Evonik Industries
    • Ashland
    • Merck KGaA
Product Code: GVR-4-68040-525-4

Pharmaceutical Lipid-based Excipients Market Growth & Trends:

The global pharmaceutical lipid-based excipients market size is anticipated to reach USD 2.42 billion by 2030 and is anticipated to expand at a CAGR of 4.8% during the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of poorly soluble drug candidates, representing 87% of pipeline candidates, has driven the adoption of advanced excipient solutions. Lipid-based excipients such as solid lipid nanoparticles and self-emulsifying drug delivery systems have become essential for complex molecules, addressing formulation challenges effectively. This surge reflects the pharmaceutical industry's need for innovative solutions to enhance drug bioavailability and efficacy.

The integration of lipid-based excipients has revolutionized mRNA vaccines and gene therapies, as highlighted during the COVID-19 pandemic. Moreover, the demand for cost-effective excipients has further increased due to patent expirations for major pharmaceutical drugs. These factors underscore the transformative impact of lipid excipients on modern pharmaceutical development and their role in driving innovation in drug delivery.

Advancements in artificial intelligence (AI) and formulation technologies further contribute to the growth of the lipid excipients market. AI-driven modeling accelerates lipid based formulations, enhancing predictability and reducing time-to-market. Regulatory bodies maintain high expectations for lipid excipients, prioritizing patient safety by focusing on purity and safety characteristics, ultimately ensuring the quality and effectiveness of pharmaceutical products.

Pharmaceutical Lipid-based Excipients Market Report Highlights:

  • Based on excipients, oil excipients dominated the market in 2024, accounting for 40.5% of the total revenue due to advancements in lipid drug delivery, nutraceutical use, and demand for sustainable ingredients.
  • The lecithin and phospholipids segment is projected to grow at a robust CAGR over the forecast period.
  • Based on product applications, topical formulations led the market with the largest revenue share in 2024; however, ophthalmic applications are expected to grow at the fastest rate of 6.7% over the forecast period.
  • Based on disease, oncological applications of lipid-based excipients garnered the largest revenue in 2024, aided by a growing pipeline of targeted therapies and immunotherapies for cancer.
  • Based on industry, the nutraceutical (dietary supplements & others) segment is expected to witness the fastest CAGR over the forecast period, fueled by strategic partnerships between lipid excipient manufacturers and supplement-focused pharmaceutical companies.
  • As aging-related conditions become more widespread, the geriatric products (65+ years) segment is expected to witness the fastest CAGR of over 5.0% over the forecast period.
  • Based on end use, pharmaceutical manufacturers emerged as dominant end users in the market in 2024, accounting for 64.9% of the total revenue.
  • In April 2024, IOI Oleo GmbH launched DYNASAN CrystalCONTROL L for the cosmetics industry. This product addresses the "blooming" effect in stick formulations, improving product stability and aesthetics for a worry-free process globally.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Regional Scope
    • 1.1.2 Estimates And Forecast Timeline
    • 1.1.3 Objectives
    • 1.1.4 Objective - 1
    • 1.1.5 Objective - 2
    • 1.1.6 Objective - 3
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Market Evaluation Methodology:
  • 1.7 List Of Secondary Sources
  • 1.8 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot (Regional)
  • 2.2 Segment Snapshot (Excipient Type)
  • 2.3 Segment Snapshot (Product Application)
  • 2.4 Segment Snapshot (Disease Application)
  • 2.5 Segment Snapshot (Product Industry & Age-based Product)
  • 2.6 Segment Snapshot (Product Industry & Age-based Product)
  • 2.7 Segment Snapshot (End-use)
  • 2.8 Competitive Landscape

Chapter 3 Manufacturers Perspective: Market Variables, Trends, and Scope

  • 3.1 Pharmaceutical Lipid-Based Excipients Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
      • 3.1.1.1 Excipient Market
    • 3.1.2 Ancillary Market Outlook
      • 3.1.2.1 Polymers Excipient Market
      • 3.1.2.2 Sugars Excipient Market
      • 3.1.2.3 Minerals Excipient Market
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Proliferation of Drug Candidates with Low Water Solubility and Bioavailability Challenges
      • 3.2.1.2 Growing Application of Lipid Excipients in Biologics and RNA-based Therapeutics
      • 3.2.1.3 Impact of Patent Expirations on Generic Drug Production and Lipid Excipients Demand
    • 3.2.2 Market Opportunities Analysis
      • 3.2.2.1 Expansion of Pharmaceutical Manufacturing in Emerging Markets as a Growth Opportunity for Lipid Excipients
      • 3.2.2.2 Growth of Local Manufacturers Enhancing Competition and Innovation in the Lipid Excipients Market
    • 3.2.3 Market Restraint Analysis
      • 3.2.3.1 Price Sensitivity in Emerging Markets Restricting the Adoption of Premium Lipid Excipients
      • 3.2.3.2 Market Dominance by Key Players Restricting Entry and Innovation in Lipid Excipients Sector
    • 3.2.4 Market Challenges Analysis
      • 3.2.4.1 Substantial R&D Investment Requirements for Developing Novel Lipid Excipients and Delivery Systems
      • 3.2.4.2 Global Regulatory and Compliance Complexities Adding Operational Challenges for Lipid Excipients Manufacturers
  • 3.3 Pharmaceutical Lipid-Based Excipients Market Analysis Tools
    • 3.3.1 PORTER'S Five Forces Analysis
  • 3.4 Customer Needs, Pains, and Gains Analysis

Chapter 4 Manufacturers Competitive Landscape of Lipid-based Excipients

  • 4.1 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 4.2 Company Profiles for Manufacturers of Lipid Excipients
    • 4.2.1 ABITEC (ABF INGREDIENTS).
      • 4.2.1.1 Company Overview
      • 4.2.1.2 Financial Overview
      • 4.2.1.3 Product Overview
      • 4.2.1.4 Key Strategic initiatives
    • 4.2.2 BASF CORPORATION
      • 4.2.2.1 Company Overview
      • 4.2.2.2 Financial Overview
      • 4.2.2.3 Product Overview
      • 4.2.2.4 Strategic Initiatives
    • 4.2.3 GATTEFOSSE
      • 4.2.3.1 Company Overview
      • 4.2.3.2 Financial Overview
      • 4.2.3.3 Product Overview
      • 4.2.3.4 Strategic Initiatives
    • 4.2.4 CORDENPHARMA
      • 4.2.4.1 Company Overview
      • 4.2.4.2 Financial Overview
      • 4.2.4.3 Product Overview
      • 4.2.4.4 Strategic Initiatives
    • 4.2.5 LIPOID GMBH
      • 4.2.5.1 Company Overview
      • 4.2.5.2 Financial Overview
      • 4.2.5.3 product Overview
      • 4.2.5.4 Key Strategic Initiatives
    • 4.2.6 IOI OLEO GMBH
      • 4.2.6.1 Company overview
      • 4.2.6.2 Financial Overview
      • 4.2.6.3 Product Overview
      • 4.2.6.4 Strategic initiatives
    • 4.2.7 CRODA INTERNATIONAL PLC
      • 4.2.7.1 Company Overview
      • 4.2.7.2 Financial Overview
      • 4.2.7.3 Product Overview
      • 4.2.7.4 Strategic Initiatives
    • 4.2.8 EVONIK INDUSTRIES AG
      • 4.2.8.1 Company Overview
      • 4.2.8.2 Financial Overview
      • 4.2.8.3 Product Overview
      • 4.2.8.4 Strategic Initiatives
    • 4.2.9 ASHLAND
      • 4.2.9.1 Company Overview
      • 4.2.9.2 Financial Overview
      • 4.2.9.3 Product Overview
      • 4.2.9.4 Strategic Initiatives
    • 4.2.10 MERCK KGAA
      • 4.2.10.1 Company Overview
      • 4.2.10.2 Financial Overview: Thermo Fisher Scientific
      • 4.2.10.3 Product Overview
      • 4.2.10.4 Strategic Initiatives
  • 4.3 Company Market Share Analysis, 2024
  • 4.4 Heatmap analysis

Chapter 5 End User Perspective: Market Variables, Trends, and Scope

  • 5.1 Pharmaceutical Lipid-Based Excipients Market Outlook - End User (Buyer/Consumer Companies) Perspective
    • 5.1.1 Market Driver Analysis
      • 5.1.1.1 Innovation in formulation development
      • 5.1.1.2 End user companies are formulating drugs for pediatric, geriatric, and chronic disease markets
      • 5.1.1.3 The Influence of ESG Objectives on the Adoption of Sustainable Lipid Excipients by End Users
    • 5.1.2 Market Opportunities Analysis
      • 5.1.2.1 Impact of Patent Expirations on Generic Drug Production and Lipid Excipients Demand
      • 5.1.2.2 Increasing prevalence of chronic diseases driving demand for lipid based formulations
    • 5.1.3 Market Restraint Analysis
      • 5.1.3.1 High R&D Costs, a Restraint for end use Pharmaceutical Companies Using Lipid-Based Excipients
      • 5.1.3.2 Regulatory Complexity
    • 5.1.4 Market Challenges Analysis
      • 5.1.4.1 Incompatibility with the active pharmaceutical ingredient (API)
      • 5.1.4.2 Stability and Shelf-Life Concerns
  • 5.2 Pharmaceutical Lipid-Based Excipients Market Analysis Tools
    • 5.2.1 PORTER'S Five Forces Analysis

Chapter 6 End User Analysis (Buyer/Consumer Companies) Competitive Landscape

  • 6.1 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 6.2 Buyer/Consumer Company Profiles
    • 6.2.1 TEVA PHARMACEUTICAL INDUSTRIES LTD.
      • 6.2.1.1 Company Overview
      • 6.2.1.2 Financial Overview
      • 6.2.1.3 Product Overview
      • 6.2.1.4 Key Strategic initiatives
    • 6.2.2 VIATRIS INC. (FORMERLY MYLAN)
      • 6.2.2.1 Company Overview
      • 6.2.2.2 Financial Overview
      • 6.2.2.3 PRODUCT OVERVIEW
      • 6.2.2.4 Strategic Initiatives
    • 6.2.3 SANDOZ (A DIVISION OF NOVARTIS)
      • 6.2.3.1 Company Overview
      • 6.2.3.2 Financial Overview
      • 6.2.3.3 Product Overview
    • 6.2.4 SUN PHARMACEUTICAL INDUSTRIES LTD.
      • 6.2.4.1 Company Overview
      • 6.2.4.2 Financial Overview
      • 6.2.4.3 Product Overview
    • 6.2.5 CIPLA LTD.
      • 6.2.5.1 Company Overview
      • 6.2.5.2 Financial Overview
      • 6.2.5.3 product Overview
      • 6.2.5.4 Key Strategic Initiatives
    • 6.2.6 DR. REDDY'S LABORATORIES LTD.
      • 6.2.6.1 Company overview
      • 6.2.6.2 Financial Overview
      • 6.2.6.3 Product Overview
      • 6.2.6.4 Strategic initiatives
    • 6.2.7 AUROBINDO PHARMA LTD.
      • 6.2.7.1 Company Overview
      • 6.2.7.2 Financial Overview
      • 6.2.7.3 Product Overview
      • 6.2.7.4 Strategic Initiatives
    • 6.2.8 LUPIN LTD.
      • 6.2.8.1 Company Overview
      • 6.2.8.2 Financial Overview
      • 6.2.8.3 Product Overview
    • 6.2.9 ZYDUS LIFESCIENCES LTD. (FORMERLY CADILA)
      • 6.2.9.1 Company Overview
      • 6.2.9.2 Financial Overview
      • 6.2.9.3 Product Overview
      • 6.2.9.4 Strategic Initiatives
    • 6.2.10 HIKMA PHARMACEUTICALS PLC
      • 6.2.10.1 Company Overview
      • 6.2.10.2 Financial Overview: Hikma Pharmaceuticals PLC
      • 6.2.10.3 Product Overview
  • 6.3 Heatmap analysis

Chapter 7 Pharmaceutical Lipid-Based Excipients Market, By Excipient Type, 2018 - 2030 (USD Million)

  • 7.1 Pharmaceutical Lipid-Based Excipients Market: Excipient Type Analysis
  • 7.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Excipient Type, 2018 - 2030 (USD Million)
    • 7.2.1 Oils
      • 7.2.1.1 Sesame Oil
      • 7.2.1.2 Soybean Oil
      • 7.2.1.3 Sunflower Oil
      • 7.2.1.4 Linseed Oil /Flaxseed Oil
      • 7.2.1.5 Safflower Oil
      • 7.2.1.6 Coconut Oil
      • 7.2.1.7 Arachis Oil / Peanut Oil
      • 7.2.1.8 Corn Oil / Maize Oil
      • 7.2.1.9 Olive Oil
      • 7.2.1.10 Almond Oil
      • 7.2.1.11 Castor Oil
      • 7.2.1.12 Cotton Seed Oil
      • 7.2.1.13 Grapeseed Oil
      • 7.2.1.14 Other Oils
    • 7.2.2 Hydrogenated Vegetable Oils
    • 7.2.3 GMCC
    • 7.2.4 Hard Fats
    • 7.2.5 Medium Chain Triglycerides (MCTS)
    • 7.2.6 Lecithin And Phospholipids
    • 7.2.7 Sodium Oleate
    • 7.2.8 Capri Caprylic Mono Diglyceride
    • 7.2.9 Other Excipient Types

Chapter 8 Pharmaceutical Lipid-Based Excipients Market, By Product Applications, 2018 - 2030 (USD Million)

  • 8.1 Pharmaceutical Lipid-Based Excipients Market: Product Application Analysis
  • 8.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Product Application, 2018 - 2030 (USD Million)
    • 8.2.1 Oral Formulations
      • 8.2.1.1 Softgel Capsules
      • 8.2.1.2 Solid Dosage
      • 8.2.1.3 Liquid Oral
      • 8.2.1.4 Solid Lipid Nanoparticles (Slns)
    • 8.2.2 Parenteral
      • 8.2.2.1 Small Volume Parenteral
      • 8.2.2.2 Large Volume Parenteral
    • 8.2.3 Topical Applications
      • 8.2.3.1 Creams
      • 8.2.3.2 Ointments
      • 8.2.3.3 Other Topical Applications
    • 8.2.4 Ophthalmic Applications
      • 8.2.4.1 Eye Drops
      • 8.2.4.2 Ocular Emulsions
    • 8.2.5 Suppositories
      • 8.2.5.1 Rectal Suppositories
      • 8.2.5.2 Vaginal Suppositories
      • 8.2.5.3 Other Suppositories
    • 8.2.6 Other Product Applications

Chapter 9 Pharmaceutical Lipid-Based Excipients Market, By Disease Application, 2018 - 2030 (USD Million)

  • 9.1 Pharmaceutical Lipid-Based Excipients Market: Disease Application Analysis
  • 9.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Disease Application, 2018 - 2030 (USD Million)
    • 9.2.1 Cardiovascular Diseases
    • 9.2.2 Neurological Disorders
    • 9.2.3 Oncology
    • 9.2.4 Metabolic Disorders
    • 9.2.5 Hormonal Therapies
    • 9.2.6 Infectious Diseases
    • 9.2.7 Other Disease Applications

Chapter 10 Pharmaceutical Lipid-Based Excipients Market, By Product Industry, 2018 - 2030 (USD Million)

  • 10.1 Pharmaceutical Lipid-Based Excipients Market: Product Industry Analysis
  • 10.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Product Industry, 2018 - 2030 (USD Million)
    • 10.2.1 Pharmaceutical (OTC & RX)
    • 10.2.2 Nutraceutical (Dietary Supplements & Other)

Chapter 11 Pharmaceutical Lipid-Based Excipients Market, By Age-Based Product, 2018 - 2030 (USD Million)

  • 11.1 Pharmaceutical Lipid-Based Excipients Market: Age-Based Product Analysis
  • 11.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Age-Based Product, 2018 - 2030 (USD Million)
    • 11.2.1 Pediatric Products (0-18 Years)
    • 11.2.2 Adult Products (19-64 Years)
    • 11.2.3 Geriatric Products (65+ Years)

Chapter 12 Pharmaceutical Lipid-Based Excipients Market, By End-Use, 2018 - 2030 (USD Million)

  • 12.1 Pharmaceutical Lipid-Based Excipients Market: End-Use Product Analysis
  • 12.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by End-Use, 2018 - 2030 (USD Million)
    • 12.2.1 Pharmaceutical Manufacturers
    • 12.2.2 Contract Development And Manufacturing Organizations (CDMOS)
    • 12.2.3 Other

Chapter 13 Pharmaceutical Lipid-Based Excipients Market: Regional Estimates and Trend Analysis

  • 13.1 Pharmaceutical Lipid-Based Excipients Market: Regional Outlook
  • 13.2 North America
    • 13.2.1 North America Pharmaceutical Lipid-Based Excipients Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 13.2.2 U.S.
      • 13.2.2.1 Key Country Dynamics
      • 13.2.2.2 U.S. Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 13.2.2.3 Competitive/Market Scenario
      • 13.2.2.4 Regulatory Framework
    • 13.2.3 Canada
      • 13.2.3.1 Key Country Dynamics
      • 13.2.3.2 Canada Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 13.2.3.3 Competitive/Market Scenario
      • 13.2.3.4 Regulatory Framework
    • 13.2.4 Mexico
      • 13.2.4.1 Key Country Dynamics
      • 13.2.4.2 Mexico Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.2.4.3 Competitive/Market Scenario
      • 13.2.4.4 Regulatory Framework
  • 13.3 Europe
    • 13.3.1 Europe Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 13.3.2 UK
      • 13.3.2.1 Key Country Dynamics
      • 13.3.2.2 UK pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.2.3 Competitive/Market Scenario
      • 13.3.2.4 Regulatory Framework
    • 13.3.3 Germany
      • 13.3.3.1 Key Country Dynamics
      • 13.3.3.2 Germany pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.3.3 Competitive/Market Scenario
      • 13.3.3.4 Regulatory Framework
    • 13.3.4 France
      • 13.3.4.1 Key Country Dynamics
      • 13.3.4.2 France pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.4.3 Competitive/Market Scenario
      • 13.3.4.4 Regulatory Framework
    • 13.3.5 Italy
      • 13.3.5.1 Key Country Dynamics
      • 13.3.5.2 Italy pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.5.3 Competitive/Market Scenario
      • 13.3.5.4 Regulatory Framework
    • 13.3.6 Spain
      • 13.3.6.1 Key Country Dynamics
      • 13.3.6.2 Spain pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.6.3 Competitive/Market Scenario
      • 13.3.6.4 Regulatory Framework
    • 13.3.7 Norway
      • 13.3.7.1 Key Country Dynamics
      • 13.3.7.2 Norway Pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.7.3 Competitive/Market Scenario
      • 13.3.7.4 Regulatory Framework
    • 13.3.8 Sweden
      • 13.3.8.1 Key Country Dynamics
      • 13.3.8.2 Sweden pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.8.3 Competitive/Market Scenario
      • 13.3.8.4 Regulatory Framework
    • 13.3.9 Denmark
      • 13.3.9.1 Key Country Dynamics
      • 13.3.9.2 Denmark Pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
      • 13.3.9.3 Competitive/Market Scenario
      • 13.3.9.4 Regulatory Framework
    • 13.3.10 Rest Of Europe Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 13.4 Asia Pacific
    • 13.4.1 Asia Pacific Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 13.4.2 China
      • 13.4.2.1 Key Country Dynamics
      • 13.4.2.2 China pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.4.2.3 Competitive/Market Scenario
      • 13.4.2.4 Regulatory Framework
    • 13.4.3 India
      • 13.4.3.1 Key Country Dynamics
      • 13.4.3.2 India pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.4.3.3 Competitive/Market Scenario
      • 13.4.3.4 Regulatory Framework
    • 13.4.4 South Korea
      • 13.4.4.1 Key Country Dynamics
      • 13.4.4.2 South Korea pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.4.4.3 Competitive/Market Scenario
      • 13.4.4.4 Regulatory Framework
    • 13.4.5 Rest Of Asia Pacific Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 13.5 Latin America
    • 13.5.1 Latin America Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 13.5.2 Brazil
      • 13.5.2.1 Key Country Dynamics
      • 13.5.2.2 Brazil pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.5.2.3 Competitive/Market Scenario
      • 13.5.2.4 Regulatory Framework
    • 13.5.3 Argentina
      • 13.5.3.1 Key Country Dynamics
      • 13.5.3.2 Argentina pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.5.3.3 Competitive/Market Scenario
      • 13.5.3.4 Regulatory Framework
    • 13.5.4 Rest Of Latin America Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 13.6 MEA
    • 13.6.1 MEA Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 13.6.2 South Africa
      • 13.6.2.1 Key Country Dynamics
      • 13.6.2.2 South Africa Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.2.3 Competitive/Market Scenario
      • 13.6.2.4 Regulatory Framework
    • 13.6.3 Saudi Arabia
      • 13.6.3.1 Key Country Dynamics
      • 13.6.3.2 Saudi Arabia pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.3.3 Competitive/Market Scenario
      • 13.6.3.4 Regulatory Framework
    • 13.6.4 UAE
      • 13.6.4.1 Key Country Dynamics
      • 13.6.4.2 UAE pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.4.3 Competitive/Market Scenario
      • 13.6.4.4 Regulatory Framework
    • 13.6.5 Jordan
      • 13.6.5.1 Key Country Dynamics
      • 13.6.5.2 Jordan pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.5.3 Competitive/Market Scenario
      • 13.6.5.4 Regulatory Framework
    • 13.6.6 Egypt
      • 13.6.6.1 Key Country Dynamics
      • 13.6.6.2 Egypt pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.6.3 Competitive/Market Scenario
      • 13.6.6.4 Regulatory Framework
    • 13.6.7 Iran
      • 13.6.7.1 Key Country Dynamics
      • 13.6.7.2 Iran pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.7.3 Competitive/Market Scenario
      • 13.6.7.4 Regulatory Framework
    • 13.6.8 Kuwait
      • 13.6.8.1 Key Country Dynamics
      • 13.6.8.2 Kuwait pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.8.3 Competitive/Market Scenario
      • 13.6.8.4 Regulatory Framework
    • 13.6.9 Rest Of MEA Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 14 Competitive Landscape

  • 14.1. Market Participant Categorization
  • 14.2. Company Market Position Analysis/ Heap Map Analysis
  • 14.3. Strategy Mapping
    • 14.3.1. Mergers & Acquisitions
    • 14.3.2. Partnerships & Collaborations
    • 14.3.3. Others
  • 14.4. Company Profiles
    • 14.4.1. ABITEC Corporation
    • 14.4.2. BASF
    • 14.4.3. Gattefosse
    • 14.4.4. CordenPharma
    • 14.4.5. Lipoid
    • 14.4.6. IOI Oleo GmbH
    • 14.4.7. Croda International
    • 14.4.8. Evonik Industries
    • 14.4.9. Ashland
    • 14.4.10. Merck KGaA

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Company market share, 2024
  • Table 4. Projected number of adults 50 years and older with chronic disease in the U.S. (in Million)
  • Table 5. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by excipient type, 2018 - 2030 (USD Million)
  • Table 6. Oil excipient market analysis
  • Table 7. Sesame oil excipient market analysis
  • Table 8. Soybean excipient market analysis
  • Table 9. Sunflower excipient market analysis
  • Table 10. Linseed oil /flaxseed oil excipient market analysis
  • Table 11. Safflower oil excipient market analysis
  • Table 12. Coconut oil excipient market analysis
  • Table 13. Peanut oil excipient market analysis
  • Table 14. Corn oil/ maize oil excipient market analysis
  • Table 15. Olive oil excipient market analysis
  • Table 16. Almond oil excipient market analysis
  • Table 17. Castor oil excipient market analysis
  • Table 18. Cotton seed oil excipient market analysis
  • Table 19. Grape seed oil excipient market analysis
  • Table 20. Cotton seed oil excipient market analysis
  • Table 21. Hydrogenated vegetable oils excipient market analysis
  • Table 22. GMCC excipient market analysis
  • Table 23. Hard fat vegetable oils excipient market analysis
  • Table 24. MCT excipient market analysis
  • Table 25. Lecithin and phospholipids excipient market analysis
  • Table 26. Sodium oleate excipient market analysis
  • Table 27. Capri caprylic mono diglyceride excipient market analysis
  • Table 28. Other types excipient market analysis
  • Table 29. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by product application, 2018 - 2030 (USD Million)
  • Table 30. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by Disease application, 2018 - 2030 (USD Million)
  • Table 31. Global heart & circulatory disease prevalence in 2021 and deaths 2021
  • Table 32. Global risk factors for heart & circulatory diseases (CVD)
  • Table 33. Alzheimer's disease prevalence in various countries
  • Table 34. Parkinson's disease prevalence in various countries
  • Table 35. New cases and deaths for 36 cancers and all cancers combined in 2022
  • Table 36. Incidence and mortality rates (age-standardized rate per 100,000, cumulative risk) for 24 world areas and by sex for all cancers combined (including nonmelanoma skin cancer except basal cell carcinoma) in 2022.
  • Table 37. Estimated number, percentage, and awareness of prediabetes among adults aged 18 years or older, U.S., 2017 - 2020 and 2021
  • Table 38. Global diabetes data report 2000 - 2045
  • Table 39. Prevalence of some of the endocrine disorders in 2022
  • Table 40. Global and regional estimates of TB incidence, numbers (in thousands) and rates (per 100 000 population) in 2023
  • Table 41. Global and regional estimates of TB mortality, numbers (in thousands) and rates (per 100 000 population) in 2023
  • Table 42. Subgroup analysis of the prevalence of Dry Eye Disorder in Asia
  • Table 43. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by product industry, 2018 - 2030 (USD Million)
  • Table 44. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by age-based product, 2018 - 2030 (USD Million)
  • Table 45. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by end-use, 2018 - 2030 (USD Million)
  • Table 46. Key lipid excipients manufacturers in the U.S.
  • Table 47. Key end user of lipid excipients in the U.S.
  • Table 48. Key lipid excipients manufacturers in the Canada
  • Table 49. Key end user of lipid excipients in the Canada
  • Table 50. Key lipid excipients manufacturers in the Mexico
  • Table 51. Key end user of lipid excipients in the Mexico
  • Table 52. Key lipid excipients manufacturers in the UK
  • Table 53. Key end user of lipid excipients in the UK
  • Table 54. Key lipid excipients manufacturers in the Germany
  • Table 55. Key end user of lipid excipients in the Germany
  • Table 56. Key lipid excipients manufacturers in the France
  • Table 57. Key end user of lipid excipients in the France
  • Table 58. Key lipid excipients manufacturers in Itay.
  • Table 59. Key End users of lipid excipients in Italy
  • Table 60. Key lipid excipients manufacturers in Spain.
  • Table 61. Key End users of lipid excipients in Spain
  • Table 62. Key lipid excipients manufacturers in the Norway.
  • Table 63. Key End users of lipid excipients in the Norway
  • Table 64. Key lipid excipients manufacturers in Sweden.
  • Table 65. Key End users of lipid excipients in Sweden
  • Table 66. Key lipid excipients manufacturers in Denmark.
  • Table 67. Key End users of lipid excipients in Denmark
  • Table 68. Key lipid excipients manufacturers in China.
  • Table 69. Key End users of lipid excipients in China
  • Table 70. Key lipid excipients manufacturers in India.
  • Table 71. Key End users of lipid excipients in India
  • Table 72. Key lipid excipients manufacturers in the South Korea
  • Table 73. Key end user of lipid excipients in the South Korea
  • Table 74. Key lipid excipients manufacturers in Brazil.
  • Table 75. Key End users of lipid excipients in Brazil
  • Table 76. Key lipid excipients manufacturers in Argentina.
  • Table 77. Key End users of lipid excipients in Argentina
  • Table 78. Key lipid excipients manufacturers in South Africa.
  • Table 79. Key End users of lipid excipients in South Africa
  • Table 80. Key lipid excipients manufacturers in Saudi Arabia.
  • Table 81. Key End users of lipid excipients in Saudi Arabia
  • Table 82. Key lipid excipients manufacturers in UAE.
  • Table 83. Key End users of lipid excipients in UAE
  • Table 84. Key lipid excipients manufacturers in Jordan.
  • Table 85. Key End users of lipid excipients in Jordan
  • Table 86. Key lipid excipients manufacturers in Egypt.
  • Table 87. Key End users of lipid excipients in Egypt
  • Table 88. Key lipid excipients manufacturers in Iran.
  • Table 89. Key End users of lipid excipients in Iran
  • Table 90. Key End users of lipid excipients in Kuwait

List of Figures

  • Fig. 1 Pharmaceutical lipid-based excipients market: Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot (Excipient type)
  • Fig. 10 Segment snapshot (Product Application)
  • Fig. 11 Segment snapshot (Disease Application)
  • Fig. 12 Segment snapshot (Product industry & age-based product)
  • Fig. 13 Segment snapshot (Product industry & age-based product)
  • Fig. 14 Segment snapshot (End-use)
  • Fig. 15 Competitive landscape
  • Fig. 16 Excipients market estimates and forecast, 2018-2030, USD Million
  • Fig. 17 Market dynamics
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • Fig. 20 Company market share analysis, 2024
  • Fig. 21 Heatmap analysis
  • Fig. 22 Porter's five forces analysis
  • Fig. 23 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • Fig. 24 Heatmap analysis
  • Fig. 25 Pharmaceutical Lipid-Based Excipients Market: Excipient Type outlook and key takeaways
  • Fig. 26 Pharmaceutical Lipid-Based Excipients Market: Excipient type movement analysis
  • Fig. 27 Oils market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Sesame oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Soybean oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Sunflower oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Linseed oil /flaxseed oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Safflower oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Coconut oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Arachis oil / peanut oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Corn oil / maize oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Olive oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Almond oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Castor oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Grapeseed oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Other oils market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Hydrogenated vegetable oils market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 GMCC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Hard fats market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Medium Chain triglycerides (MCTs) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Lecithin and phospholipids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Sodium oleate market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Capri caprylic mono diglyceride market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Other excipient types market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Pharmaceutical Lipid-Based Excipients Market: Product Application outlook and key takeaways
  • Fig. 50 Pharmaceutical Lipid-Based Excipients Market: Product application movement analysis
  • Fig. 51 Oral formulations market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Softgel capsules market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Solid dosage market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Liquid oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Liquid oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Parenteral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Small volume parenteral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Large volume parenteral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Topical applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Creams market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Ointments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Other topical applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Ophthalmic applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Eye drops market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Ocular emulsions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Suppositories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Rectal suppositories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Vaginal suppositories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Other Suppositories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Other product applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Pharmaceutical Lipid-Based Excipients Market: Disease Application outlook and key takeaways
  • Fig. 72 Pharmaceutical Lipid-Based Excipients Market: Disease Application movement analysis
  • Fig. 73 Cardiovascular diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Metabolic disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Hormonal therapies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Other disease applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Pharmaceutical Lipid-Based Excipients Market Product Industry outlook and key takeaways
  • Fig. 81 Pharmaceutical Lipid-Based Excipients Market: Product Industry movement analysis
  • Fig. 82 Pharmaceutical (OTC & Rx) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Nutraceutical (dietary supplements & other) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Pharmaceutical Lipid-Based Excipients Market Age-Based Product outlook and key takeaways
  • Fig. 85 Pharmaceutical Lipid-Based Excipients Market: Age-Based Product movement analysis
  • Fig. 86 Pediatric products (0-18 years) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Adult products (19-64 years) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Geriatric products (65+ years) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Pharmaceutical Lipid-Based Excipients Market End-Use outlook and key takeaways
  • Fig. 90 Pharmaceutical Lipid-Based Excipients Market: End-Use Product movement analysis
  • Fig. 91 Pharmaceutical manufacturers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Contract Development and Manufacturing Organizations (CDMOs) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Pharmaceutical Lipid-Based Excipients Market, revenue, by region, 2024 & 2030 (USD million)
  • Fig. 95 Regional marketplace: Key takeaways
  • Fig. 96 Regional marketplace: Key takeaways
  • Fig. 97 North America pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 U.S. pharmaceutical lipid-based excipients, market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Canada pharmaceutical lipid-based Excipients, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Mexico pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030, USD Million
  • Fig. 104 Europe pharmaceutical lipid-based Excipients, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 UK pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Germany pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Key country dynamics
  • Fig. 110 France pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 Key country dynamics
  • Fig. 112 Italy pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 113 Key country dynamics
  • Fig. 114 Spain pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 115 Key country dynamics
  • Fig. 116 Norway pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 117 Key country dynamics
  • Fig. 118 Sweden pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 119 Key country dynamics
  • Fig. 120 Denmark pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 121 Rest of Europe pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 122 Asia Pacific pharmaceutical lipid-based Excipients, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 123 Key country dynamics
  • Fig. 124 China pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 125 Key country dynamics
  • Fig. 126 India pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 127 Key country dynamics
  • Fig. 128 South Korea pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 129 Rest of Asia Pacific pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 130 Latin America pharmaceutical lipid-based excipients, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 131 Key country dynamics
  • Fig. 132 Brazil pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 133 Key country dynamics
  • Fig. 134 Argentina pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 135 Rest of Latin America pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 136 MEA pharmaceutical lipid-based excipients, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 137 Key country dynamics
  • Fig. 138 South Africa pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 139 Key country dynamics
  • Fig. 140 Saudi Arabia pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 141 Key country dynamics
  • Fig. 142 UAE pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 143 Key country dynamics
  • Fig. 144 Jordan pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 145 Key country dynamics
  • Fig. 146 Egypt pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 147 Key country dynamics
  • Fig. 148 Iran pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 149 Key country dynamics
  • Fig. 150 Kuwait pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 151 Rest of MEA pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)